RTI 598929
Latest Information Update: 30 Jul 2002
Price :
$50 *
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Opioid kappa receptor antagonists; Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Heroin-related disorders
Most Recent Events
- 22 Oct 1999 New profile
- 22 Oct 1999 Preclinical development for Heroin abuse in USA (Unknown route)